Skip to main content
Erschienen in: World Journal of Urology 8/2019

06.04.2019 | Topic Paper

Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review

verfasst von: Giorgio Calleris, Giancarlo Marra, Ettore Dalmasso, Marco Falcone, Robert Jeffrey Karnes, Alessandro Morlacco, Marco Oderda, Rafael Sanchez-Salas, Francesco Soria, Paolo Gontero

Erschienen in: World Journal of Urology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Salvage radical prostatectomy (sRP) represents a curative option for prostate cancer (PCa) biochemical recurrence (BCR) after radiation therapy (RT). In this review, we aimed to outline the contemporary results and use of sRP.

Methods

A web search was performed on the Ovid platform using Embase and Medline databases from January 2010 using pre-defined search terms. Web search was implemented by manual search. Oncological and functional outcomes and complications were summarized using standard classification systems, when feasible.

Results

sRP is currently underused, being chosen for radio-recurrent PCa treatment in around 1% of the cases. Surgery is complex due to radiation-induced tissue changes making posterior planes and apex dissection particularly challenging. Patient selection is paramount to maximize the oncological benefit. Most series report a BCR-free survival > 60%, mainly at the end of a short- to intermediate-term follow-up. Five-year progression-free survival is nearly 50% and 5-year cancer-specific survival rates are around 90%. Major peri-operative complications, anastomotic leaks and strictures, still more frequent than in a primary RP setting, have been steering towards more acceptable rates in recent years, when compared to historical series. Continence rates are widely variable, often in between 39 and 60%. Potency remains difficult to recover.

Conclusions

sRP represents a curative option with promising short- to medium-term oncological results and acceptable side effects, in high-volume institutions. In appropriately selected patients, the procedure should not be underused due to the fear of poor functional outcomes and/or complications. Prospective studies are needed to assess the long-term outcomes and to further refine patient selection criteria.
Literatur
1.
Zurück zum Zitat Agarwal PK et al (2008) Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 112(2):307–314PubMed Agarwal PK et al (2008) Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 112(2):307–314PubMed
2.
Zurück zum Zitat Shipley WU et al (1999) Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 281(17):1598–1604PubMed Shipley WU et al (1999) Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 281(17):1598–1604PubMed
3.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30PubMed Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68(1):7–30PubMed
4.
Zurück zum Zitat Cookson MM (2001) Prostate cancer: screening and early detection. Cancer Control 8(2):133–140PubMed Cookson MM (2001) Prostate cancer: screening and early detection. Cancer Control 8(2):133–140PubMed
5.
Zurück zum Zitat Cary KC et al (2015) Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project. Prostate Cancer Prostatic Dis 18(2):149–154PubMedPubMedCentral Cary KC et al (2015) Nationally representative trends and geographic variation in treatment of localized prostate cancer: the Urologic Diseases in America project. Prostate Cancer Prostatic Dis 18(2):149–154PubMedPubMedCentral
6.
Zurück zum Zitat Malouff T et al (2017) Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database. Prostate Cancer Prostatic Dis 20(3):334–338PubMed Malouff T et al (2017) Trends in the use of radiation therapy for stage IIA prostate cancer from 2004 to 2013: a retrospective analysis using the National Cancer Database. Prostate Cancer Prostatic Dis 20(3):334–338PubMed
7.
Zurück zum Zitat Lievens Y et al (2017) Radiotherapy access in Belgium: how far are we from evidence-based utilisation? Eur J Cancer 84:102–113PubMed Lievens Y et al (2017) Radiotherapy access in Belgium: how far are we from evidence-based utilisation? Eur J Cancer 84:102–113PubMed
8.
Zurück zum Zitat Chen J et al (2018) National trends in management of localized prostate cancer: a population based analysis 2004–2013. Prostate 78(7):512–520PubMed Chen J et al (2018) National trends in management of localized prostate cancer: a population based analysis 2004–2013. Prostate 78(7):512–520PubMed
9.
Zurück zum Zitat Golbari NM, Katz AE (2017) Salvage therapy options for local prostate cancer recurrence after primary radiotherapy: a literature review. Curr Urol Rep 18(8):63PubMed Golbari NM, Katz AE (2017) Salvage therapy options for local prostate cancer recurrence after primary radiotherapy: a literature review. Curr Urol Rep 18(8):63PubMed
10.
Zurück zum Zitat Mador DR et al (1985) Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate. J Urol 133(1):58–60PubMed Mador DR et al (1985) Salvage surgery following radical radiotherapy for adenocarcinoma of the prostate. J Urol 133(1):58–60PubMed
11.
Zurück zum Zitat Chade DC et al (2011) Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol 60(2):205–210PubMedPubMedCentral Chade DC et al (2011) Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol 60(2):205–210PubMedPubMedCentral
12.
Zurück zum Zitat Grossfeld GD et al (2002) Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 168(2):530–535PubMed Grossfeld GD et al (2002) Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 168(2):530–535PubMed
13.
Zurück zum Zitat Cary KC et al (2014) Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registry. Cancer 120(4):507–512PubMed Cary KC et al (2014) Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: an analysis from the CaPSURE registry. Cancer 120(4):507–512PubMed
14.
Zurück zum Zitat Jones JS (2011) Radiorecurrent prostate cancer: an emerging and largely mismanaged epidemic. Eur Urol 60(3):411–412PubMed Jones JS (2011) Radiorecurrent prostate cancer: an emerging and largely mismanaged epidemic. Eur Urol 60(3):411–412PubMed
15.
Zurück zum Zitat Gotto GT et al (2010) Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 184(1):136–142PubMed Gotto GT et al (2010) Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 184(1):136–142PubMed
16.
Zurück zum Zitat Stone HB et al (2003) Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 4(9):529–536PubMed Stone HB et al (2003) Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 4(9):529–536PubMed
17.
Zurück zum Zitat Chade DC et al (2012) Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 61(5):961–971PubMed Chade DC et al (2012) Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 61(5):961–971PubMed
18.
Zurück zum Zitat Zargar H et al (2017) Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis. Minerva Urol Nefrol 69(1):26–37PubMed Zargar H et al (2017) Salvage robotic prostatectomy for radio recurrent prostate cancer: technical challenges and outcome analysis. Minerva Urol Nefrol 69(1):26–37PubMed
19.
Zurück zum Zitat Eandi JA et al (2010) Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer. J Urol 183(1):133–137PubMed Eandi JA et al (2010) Robotic assisted laparoscopic salvage prostatectomy for radiation resistant prostate cancer. J Urol 183(1):133–137PubMed
20.
Zurück zum Zitat Yuh B et al (2014) Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience. BJU Int 113(5):769–776PubMed Yuh B et al (2014) Complications and outcomes of salvage robot-assisted radical prostatectomy: a single-institution experience. BJU Int 113(5):769–776PubMed
21.
Zurück zum Zitat Bonet X et al (2018) Nerve-sparing in salvage robot-assisted prostatectomy: surgical technique, oncological and functional outcomes at a single high-volume institution. BJU Int 122:837–844PubMed Bonet X et al (2018) Nerve-sparing in salvage robot-assisted prostatectomy: surgical technique, oncological and functional outcomes at a single high-volume institution. BJU Int 122:837–844PubMed
22.
Zurück zum Zitat Abdul-Muhsin H et al (2013) Salvage robot-assisted radical prostatectomy. BJU Int 111(4):686–687PubMed Abdul-Muhsin H et al (2013) Salvage robot-assisted radical prostatectomy. BJU Int 111(4):686–687PubMed
23.
Zurück zum Zitat Bates AS et al (2015) Salvage robot assisted radical prostatectomy: a propensity matched study of perioperative, oncological and functional outcomes. Eur J Surg Oncol 41(11):1540–1546PubMed Bates AS et al (2015) Salvage robot assisted radical prostatectomy: a propensity matched study of perioperative, oncological and functional outcomes. Eur J Surg Oncol 41(11):1540–1546PubMed
24.
Zurück zum Zitat Rogers E et al (1995) Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 153(1):104–110PubMed Rogers E et al (1995) Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 153(1):104–110PubMed
25.
Zurück zum Zitat Rocco B et al (2012) Current status of salvage robot-assisted laparoscopic prostatectomy for radiorecurrent prostate cancer. Curr Urol Rep 13(3):195–201PubMed Rocco B et al (2012) Current status of salvage robot-assisted laparoscopic prostatectomy for radiorecurrent prostate cancer. Curr Urol Rep 13(3):195–201PubMed
26.
Zurück zum Zitat Stephenson AJ et al (2004) Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172(6 Pt 1):2239–2243PubMed Stephenson AJ et al (2004) Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172(6 Pt 1):2239–2243PubMed
27.
Zurück zum Zitat Ogaya-Pinies G et al (2018) Use of scaffolding tissue biografts to bolster vesicourethral anastomosis during salvage robot-assisted prostatectomy reduces leak rates and catheter times. Eur Urol 74(1):92–98PubMed Ogaya-Pinies G et al (2018) Use of scaffolding tissue biografts to bolster vesicourethral anastomosis during salvage robot-assisted prostatectomy reduces leak rates and catheter times. Eur Urol 74(1):92–98PubMed
28.
Zurück zum Zitat Bandini M et al (2018) Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy. Transl Androl Urol 7(Suppl 1):S141–S143PubMedPubMedCentral Bandini M et al (2018) Anastomotic leaks and catheter time after salvage robot-assisted radical prostatectomy. Transl Androl Urol 7(Suppl 1):S141–S143PubMedPubMedCentral
29.
Zurück zum Zitat Heidenreich A et al (2010) Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur Urol 57(3):437–443PubMed Heidenreich A et al (2010) Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur Urol 57(3):437–443PubMed
30.
Zurück zum Zitat Kaffenberger SD et al (2013) Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J Urol 189(2):507–513PubMed Kaffenberger SD et al (2013) Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J Urol 189(2):507–513PubMed
31.
Zurück zum Zitat Kenney PA et al (2016) Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Can J Urol 23(3):8271–8277PubMedPubMedCentral Kenney PA et al (2016) Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Can J Urol 23(3):8271–8277PubMedPubMedCentral
32.
Zurück zum Zitat Ogaya-Pinies G et al (2018) Salvage robotic-assisted radical prostatectomy: oncologic and functional outcomes from two high-volume institutions. World J Urol. PMID:300006908 Ogaya-Pinies G et al (2018) Salvage robotic-assisted radical prostatectomy: oncologic and functional outcomes from two high-volume institutions. World J Urol. PMID:300006908
33.
Zurück zum Zitat Zugor V et al (2014) Robot-assisted radical prostatectomy for the treatment of radiation-resistant prostate cancer: surgical, oncological and short-term functional outcomes. Urol Int 92(1):20–26PubMed Zugor V et al (2014) Robot-assisted radical prostatectomy for the treatment of radiation-resistant prostate cancer: surgical, oncological and short-term functional outcomes. Urol Int 92(1):20–26PubMed
34.
Zurück zum Zitat Mandel P et al (2016) Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria. BJU Int 117(1):55–61PubMed Mandel P et al (2016) Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria. BJU Int 117(1):55–61PubMed
35.
Zurück zum Zitat Linares Espinós E et al (2016) Minimally invasive salvage prostatectomy after primary radiation or ablation treatment. Urology 94:111–116PubMed Linares Espinós E et al (2016) Minimally invasive salvage prostatectomy after primary radiation or ablation treatment. Urology 94:111–116PubMed
36.
Zurück zum Zitat Pokala N et al (2016) Survival outcomes in men undergoing radical prostatectomy after primary radiation treatment for adenocarcinoma of the prostate. Clin Genitourin Cancer 14(3):218–225PubMed Pokala N et al (2016) Survival outcomes in men undergoing radical prostatectomy after primary radiation treatment for adenocarcinoma of the prostate. Clin Genitourin Cancer 14(3):218–225PubMed
37.
Zurück zum Zitat Ou YC et al (2017) Salvage robotic-assisted laparoscopic radical prostatectomy: experience with 14 cases. Anticancer Res 37(4):2045–2050PubMed Ou YC et al (2017) Salvage robotic-assisted laparoscopic radical prostatectomy: experience with 14 cases. Anticancer Res 37(4):2045–2050PubMed
38.
Zurück zum Zitat Chauhan S et al (2011) Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes. J Endourol 25(6):1013–1019PubMed Chauhan S et al (2011) Preliminary analysis of the feasibility and safety of salvage robot-assisted radical prostatectomy after radiation failure: multi-institutional perioperative and short-term functional outcomes. J Endourol 25(6):1013–1019PubMed
39.
Zurück zum Zitat Roach M et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys 65(4):965–974PubMed Roach M et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys 65(4):965–974PubMed
40.
Zurück zum Zitat Prasad SM et al (2013) Morbidity and costs of salvage vs. primary radical prostatectomy in older men. Urol Oncol 31(8):1477–1482PubMed Prasad SM et al (2013) Morbidity and costs of salvage vs. primary radical prostatectomy in older men. Urol Oncol 31(8):1477–1482PubMed
41.
Zurück zum Zitat Barchetti F, Panebianco V (2014) Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy. Biomed Res Int 2014:316272PubMedPubMedCentral Barchetti F, Panebianco V (2014) Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy. Biomed Res Int 2014:316272PubMedPubMedCentral
42.
Zurück zum Zitat Ménard C et al (2015) MR-guided prostate biopsy for planning of focal salvage after radiation therapy. Radiology 274(1):181–191PubMed Ménard C et al (2015) MR-guided prostate biopsy for planning of focal salvage after radiation therapy. Radiology 274(1):181–191PubMed
43.
Zurück zum Zitat Goonewardene S, Alsheikh M (2018) The role of PSMA PET scans in salvage therapy planning. World J Urol 36(3):503–504PubMed Goonewardene S, Alsheikh M (2018) The role of PSMA PET scans in salvage therapy planning. World J Urol 36(3):503–504PubMed
44.
Zurück zum Zitat Sathianathen NJ, Butaney M, Konety BR (2018) The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis. World J Urol. PMID:300003375 Sathianathen NJ, Butaney M, Konety BR (2018) The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis. World J Urol. PMID:300003375
45.
Zurück zum Zitat Habl G et al (2017) Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: individualized medicine or new standard in salvage treatment. Prostate 77(8):920–927PubMed Habl G et al (2017) Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: individualized medicine or new standard in salvage treatment. Prostate 77(8):920–927PubMed
46.
Zurück zum Zitat Wilt TJ et al (2008) Association between hospital and surgeon radical prostatectomy volume and patient outcomes: a systematic review. J Urol 180(3):820–828 (discussion 828–9) PubMed Wilt TJ et al (2008) Association between hospital and surgeon radical prostatectomy volume and patient outcomes: a systematic review. J Urol 180(3):820–828 (discussion 828–9) PubMed
47.
Zurück zum Zitat Barocas DA et al (2010) Impact of surgeon and hospital volume on outcomes of radical prostatectomy. Urol Oncol 28(3):243–250PubMed Barocas DA et al (2010) Impact of surgeon and hospital volume on outcomes of radical prostatectomy. Urol Oncol 28(3):243–250PubMed
48.
Zurück zum Zitat Leow JJ et al (2016) Robot-assisted versus open radical prostatectomy: a contemporary analysis of an all-payer discharge database. Eur Urol 70(5):837–845PubMed Leow JJ et al (2016) Robot-assisted versus open radical prostatectomy: a contemporary analysis of an all-payer discharge database. Eur Urol 70(5):837–845PubMed
50.
Zurück zum Zitat Cornford P et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol 71(4):630–642PubMed Cornford P et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part II: treatment of relapsing, metastatic, and castration-resistant prostate cancer. Eur Urol 71(4):630–642PubMed
51.
Zurück zum Zitat Budäus L et al (2012) Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol 61(1):112–127PubMed Budäus L et al (2012) Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol 61(1):112–127PubMed
52.
Zurück zum Zitat Sivaraman A et al (2016) Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy. World J Urol 34:1367–1372PubMed Sivaraman A et al (2016) Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy. World J Urol 34:1367–1372PubMed
53.
Zurück zum Zitat Avulova S, Smith JA (2018) Is comparison of robotic to open radical prostatectomy still relevant? Eur Urol 73(5):672–673PubMed Avulova S, Smith JA (2018) Is comparison of robotic to open radical prostatectomy still relevant? Eur Urol 73(5):672–673PubMed
54.
Zurück zum Zitat Gontero P et al (2018) MP11-05 oncological outcomes of salvage radical prostatectomy in a contemporary, multicentre series of 395 cases. J Urol 199(4):e128–e129 Gontero P et al (2018) MP11-05 oncological outcomes of salvage radical prostatectomy in a contemporary, multicentre series of 395 cases. J Urol 199(4):e128–e129
55.
Zurück zum Zitat Gontero P et al (2018) PD29-04 complications and functional outcomes of salvage radical prostatectomy: a comparison between open and robot-assisted approaches in a multicentre series. J Urol 199(4):e568–e569 Gontero P et al (2018) PD29-04 complications and functional outcomes of salvage radical prostatectomy: a comparison between open and robot-assisted approaches in a multicentre series. J Urol 199(4):e568–e569
56.
Zurück zum Zitat Meeks JJ, Eastham JA (2013) Robotic salvage prostatectomy: underused but not for the inexperienced. J Urol 189(2):413–414PubMed Meeks JJ, Eastham JA (2013) Robotic salvage prostatectomy: underused but not for the inexperienced. J Urol 189(2):413–414PubMed
Metadaten
Titel
Is it worth to perform salvage radical prostatectomy for radio-recurrent prostate cancer? A literature review
verfasst von
Giorgio Calleris
Giancarlo Marra
Ettore Dalmasso
Marco Falcone
Robert Jeffrey Karnes
Alessandro Morlacco
Marco Oderda
Rafael Sanchez-Salas
Francesco Soria
Paolo Gontero
Publikationsdatum
06.04.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 8/2019
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02749-z

Weitere Artikel der Ausgabe 8/2019

World Journal of Urology 8/2019 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.